Literature DB >> 30401463

[Life-threatening hypercalcemia and acute kidney injury induced by etanercept].

Yawovi Mawufemo Tsevi1, Selda Aydin2, Patrick Durez3, Laura Labriola4.   

Abstract

Drug-induced sarcoidosis-like disease is a rare, but not exceptional, side effect of anti-tumor necrosis factor (anti-TNF) agents. The organs most commonly involved are lungs, skin and lymph nodes. Kidney involvement is exceptional. Histology usually reveals non-caseating granulomas. Some of the biological features usually described in sarcoidosis are very infrequent in drug-induced granulomatosis. We report a case of sarcoid-like granulomatosis manifesting as life-threatening hypercalcemia and acute kidney injury in a woman treated with etanercept for a rheumatoid arthritis. Seven days after admission, she developed hypoxemic interstitial pneumonia with negative mycobacterial and fungal analysis. This picture suggested sarcoid-like disease induced by tumor necrosis factor blockers and prompted etanercept cessation. Kidney biopsy performed 30 days after admission revealed significant acute interstitial nephritis and intratubular calcium crystals. Staining for acid-fast bacilli and fungi was negative. Clinical picture improved gradually after etanercept withdrawal and cortisone treatment. Three weeks after admission, serum creatinine and calcium levels were normal. Clinical presentation of sarcoidosis-like disease induced by anti-tumor necrosis factor agents may be extremely variable. Our observation shows that severe, life-threatening hypercalcemia may occur. Renal involvement is very unusual. This case highlights this diagnostic difficulty and the importance of a close clinical monitoring in patients treated with these drugs. Cessation of the anti-tumor necrosis factor agent leads to resolution of this condition in most cases.
Copyright © 2018 Société francophone de néphrologie, dialyse et transplantation. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Acute interstitial nephritis; Anti-TNF; Granulomatose induite; Hypercalcemia; Hypercalcémie; Néphrite interstitielle aiguë; Sarcoid-like granulomatosis

Mesh:

Substances:

Year:  2018        PMID: 30401463     DOI: 10.1016/j.nephro.2018.05.001

Source DB:  PubMed          Journal:  Nephrol Ther        ISSN: 1769-7255            Impact factor:   0.722


  2 in total

1.  Etanercept-associated Nephropathy.

Authors:  Awais Ammar; Hafiz Zafar Ahmed Mahmood; Zainab Shahid; Rohit Jain; Guoli Chen
Journal:  Cureus       Date:  2019-08-18

2.  Treatment of male and female spontaneously hypertensive rats with TNF-α inhibitor etanercept increases markers of renal injury independent of an effect on blood pressure.

Authors:  Elizabeth C Snyder; Mahmoud Abdelbary; Ahmed El-Marakby; Jennifer C Sullivan
Journal:  Biol Sex Differ       Date:  2022-04-12       Impact factor: 5.027

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.